SIG
CVS icon

Sargent Investment Group’s CVS Health CVS Stock Holding History

Sargent Investment Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Sell
4,432
-30
-0.7% -$2.31K 0.04% 200
2025
Q4 		$354K Buy
+4,462
New +$352K 0.04% 190
2025
Q3 		– Sell
-4,392
Closed -$279K – 147
2025
Q2 		$279K Sell
4,392
-55
-1% -$3.61K 0.04% 200
2025
Q1 		$301K Buy
4,447
+510
+13% +$30.5K 0.05% 187
2024
Q4 		$203K Sell
3,937
-130
-3% -$7.29K 0.03% 223
2024
Q3 		$256K Sell
4,067
-236
-5% -$13.8K 0.05% 182
2024
Q2 		$254K Sell
4,303
-740
-15% -$46.3K 0.05% 180
2024
Q1 		$402K Sell
5,043
-7,365
-59% -$563K 0.09% 127
2023
Q4 		$980K Sell
12,408
-525
-4% -$37.4K 0.21% 86
2023
Q3 		$903K Buy
12,933
+1,546
+14% +$110K 0.22% 86
2023
Q2 		$787K Buy
11,387
+730
+7% +$51.9K 0.19% 94
2023
Q1 		$811K Buy
10,657
+125
+1% +$10.5K 0.21% 89
2022
Q4 		$981K Buy
10,532
+750
+8% +$72.4K 0.3% 79
2022
Q3 		$964K Sell
9,782
-55
-0.6% -$5.44K 0.3% 72
2022
Q2 		$911K Hold
9,837
– – 0.28% 72
2022
Q1 		$996K Sell
9,837
-75
-0.8% -$7.88K 0.25% 73
2021
Q4 		$1.02M Buy
9,912
+330
+3% +$30.5K 0.23% 71
2021
Q3 		$813K Sell
9,582
-1,150
-11% -$96.3K 0.2% 85
2021
Q2 		$895K Hold
10,732
– – 0.21% 75
2021
Q1 		$807K Buy
10,732
+2,500
+30% +$182K 0.21% 80
2020
Q4 		$562K Buy
8,232
+2,031
+33% +$132K 0.18% 96
2020
Q3 		$362K Buy
6,201
+1,469
+31% +$91.4K 0.13% 114
2020
Q2 		$305K Buy
4,732
+105
+2% +$6.61K 0.11% 115
2020
Q1 		$275K Hold
4,627
– – 0.13% 113
2019
Q4 		$344K Hold
4,627
– – 0.13% 112
2019
Q3 		$292K Hold
4,627
– – 0.13% 112
2019
Q2 		$252K Sell
4,627
-700
-13% -$37.7K 0.12% 122
2019
Q1 		$287K Hold
5,327
– – 0.14% 112
2018
Q4 		$349K Buy
+5,327
New +$398K 0.21% 89

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sargent Investment Group's CVS Position: Q1 2026 in Review

Sargent Investment Group reduced its CVS Health (CVS) stake by 0.67% in Q1 2026, selling an estimated $2.31K and leaving 4,432 shares worth $318K. The position accounts for 0.04% of the portfolio, ranked #200.

Sargent Investment Group first reported a position in CVS in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.02M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Sargent Investment Group held 4,432 shares of CVS Health worth $318K as of Q1 2026.
  • Sargent Investment Group sold 30 CVS Health shares in Q1 2026, an estimated $2.31K.
  • CVS Health made up 0.04% of Sargent Investment Group's portfolio in Q1 2026, its #200 holding.
  • Sargent Investment Group first reported a position in CVS Health in Q4 2018 and has held it in 29 quarters since.
  • Sargent Investment Group's CVS Health position peaked at $1.02M in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.